Federal Register / Vol. 61, No. 93 / Monday, May 13, 1996 / Notices 22065

Name: Injury Research Grant Review

Committee (IRGRC).

Times and Dates: 6 p.m.–9 p.m., June 9,

1996; 8 a.m.–6 p.m., June 10, 1996.

Place: The Palmer House Hilton, 17 East

Monroe Street, Chicago, Illinois 60603–5605.

Status: Open: 6 p.m.–7 p.m., June 9, 1996;

Closed: 7 p.m.–9 p.m., June 9, 1996; Closed:

8 a.m.–6 p.m., June 10, 1996.

Purpose: This committee is charged with

advising the Secretary of Health and Human

Services, the Assistant Secretary for Health,

and the Director, CDC, regarding the

scientific merit and technical feasibility of

grant applications received from academic

institutions and other public and private

profit and nonprofit organizations, including

State and local government agencies, to

conduct specific injury research that focus on

prevention and control and to support injury

prevention research centers.

Matters To Be Discussed: Agenda items

include: announcements, discussion of

review procedures, future meeting dates, and

review of grant applications.

Beginning at 7 p.m., June 9, through 6 p.m.,

June 10, the Committee will meet to conduct

a review of grant applications. This portion

of the meeting will be closed to the public

in accordance with provisions set forth in

section 552b(c) (4) and (6), title 5 U.S.C., and

the Determination of the Associate Director

for Management and Operations, CDC,

pursuant to Pub. L. 92–463.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Richard W. Sattin, M.D., Executive Secretary,

IRGRC, National Center for Injury Prevention

and Control, CDC, 4770 Buford Highway,

NE., M/S K58, Atlanta, Georgia 30341–3724,

telephone 770/488–4580.

Dated: May 3, 1996.

Carolyn J. Russell,

Director, Management Analysis and Services

Office Centers for Disease Control and

Prevention (CDC).

[FR Doc. 96–11857 Filed 5–10–96; 8:45 am]

BILLING CODE 4163–18–M

Health Resources and Services

Administration

Advisory Commission on Childhood

Vaccines; Request for Nominations for

Voting Members

AGENCY: Health Resources and Services

Administration.

ACTION: Notice.

SUMMARY: The Health Resources and

Services Administration (HRSA) is

requesting nominations to fill three

vacancies on the Advisory Commission

on Childhood Vaccines (ACCV). The

ACCV was established by title XXI of

the Public Health Service Act (the Act),

as enacted by Public Law (P.L.) 99–660

and as subsequently amended, and

advises the Secretary of Health and

Human Services (the Secretary) on

issues related to implementation of the

National Vaccine Injury Compensation

Program (VICP).

FOR FURTHER INFORMATION CONTACT: Ms.

Melissa Palmer, Committee

Management Assistant, Policy and

Commission Branch, Division of

Vaccine Injury Compensation, at (301)

443–1533.

DATES: Nominations are to be submitted

by June 13, 1996.

ADDRESSES: All nominations are to be

submitted to the Director, Division of

Vaccine Injury Compensation, Bureau of

Health Professions, HRSA, Parklawn

Building, Room 8A–35, 5600 Fishers

Lane, Rockville, Maryland 20857.

SUPPLEMENTARY INFORMATION: Under the

authorities that established the ACCV,

viz., the Federal Advisory Committee

Act of October 6, 1972 (P.L. 92–463) and

section 2119 of the Act, 42 U.S.C. 300aa19, as added by P.L. 99–660 and

amended, HRSA is requesting

nominations for three voting members

of the ACCV.

The ACCV advises the Secretary on

the implementation of the VICP; on its

own initiative or as the result of the

filing of a petition, recommends changes

in the Vaccine Injury Table; advises the

Secretary in implementing the

Secretary’s responsibilities under

section 2127 regarding the need for

childhood vaccination products that

result in fewer or no significant adverse

reactions; surveys Federal, State, and

local programs and activities relating to

the gathering of information on injuries

associated with the administration of

childhood vaccines, including the

adverse reaction reporting requirements

of section 2125(b); advises the Secretary

on means to obtain, compile, publish,

and use credible data related to the

frequency and severity of adverse

reactions associated with childhood

vaccines; and recommends to the

Director, National Vaccine Program,

research related to vaccine injuries

which should be conducted to carry out

the VICP.

The ACCV consists of nine voting

members appointed by the Secretary as

follows: three health professionals, of

whom at least two are pediatricians,

who are not employees of the United

States, who have expertise in the health

care of children, the epidemiology,

etiology and prevention of childhood

diseases, and the adverse reactions

associated with vaccines; three members

from the general public, of whom at

least two are legal representatives

(parents or guardians) of children who

have suffered a vaccine-related injury or

death; and three attorneys, of whom at

least one shall be an attorney whose

specialty includes representation of

persons who have suffered a vaccinerelated injury or death and one shall be

an attorney whose specialty includes

representation of vaccine

manufacturers. In addition, the Director

of the National Institutes of Health, the

Assistant Secretary for Health, the

Director of the Centers for Disease

Control and Prevention, and the

Commissioner of the Food and Drug

Administration (or the designees of such

officials) serve as nonvoting ex officio

members.

Specifically, HRSA is requesting

nominations for three voting members

of the ACCV representing: (1) A health

professional with special experience in

childhood diseases; (2) a member from

the general public who is a legal

representative (parent or guardian) of a

child who has suffered a vaccine-related

injury or death; and (3) an attorney with

no specific affiliation (as stated above,

this category requires membership of

three attorneys, of whom at least one

shall be an attorney whose specialty

includes representation of persons who

have suffered a vaccine-related injury or

death and one of whom is an attorney

whose specialty includes representation

of vaccine manufacturers—by this

notice, the Department is soliciting

nominations for the third attorney

position). Nominees will be invited to

serve 3-year terms beginning January 1,

1997, and ending December 31, 1999.

Interested persons may nominate one

or more qualified persons for

membership on the ACCV. Nominations

shall state that the nominee is willing to

serve as a member of the ACCV and

appears to have no conflict of interest

that would preclude the ACCV

membership. Potential candidates will

be asked to provide detailed information

concerning such matters as financial

holdings, consultancies, and research

grants or contracts to permit evaluation

of possible sources of conflicts of

interest. A curriculum vitae should be

submitted with the nomination.

The Department of Health and Human

Services has special interest in assuring

that women, minority groups, and the

physically handicapped are adequately

represented on advisory committees and

therefore extends particular

encouragement to nominations for

appropriately qualified female,

minority, or physically handicapped

candidates.

Dated: May 7, 1996.

Ciro V. Sumaya,

Administrator.

[FR Doc. 96–11878 Filed 5–10–96; 8:45 am]

BILLING CODE 4160–15–P